Anavex Life Sciences's total assets for Q4 2024 were $135.57M, a decrease of -4.22% from the previous quarter. AVXL total liabilities were $15.30M for the fiscal quarter, a 30.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.